ROSEN, NATIONAL TRIAL LAWYERS, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – APLS

<p>NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) &#8212; WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) between January 28, 2021 and July 28, 2023, both dates inclusive (the “Class Period”), of the important October 2, 2023 lead plaintiff deadline. SO WHAT: If [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/rosen-national-trial-lawyers-encourages-apellis-pharmaceuticals-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-apls/">ROSEN, NATIONAL TRIAL LAWYERS, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – APLS</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>